INOVIO PHARMACEUTICALS, INC.

INO · Nasdaq · SIC 2834: Pharmaceutical Preparations
316
SEC Filings

Business Summary

Inovio Pharmaceuticals, Inc. is a pharmaceutical company. The provided filing excerpt is an auditor consent (Exhibit 23.1) from Ernst & Young LLP rather than a business description, so specific product and operational details are not available from this text. The company maintains multiple equity incentive plans including the 2007 Omnibus Incentive Plan, 2016 Omnibus Incentive Plan, 2022 Inducement Plan, and 2023 Omnibus Incentive Plan.

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionINOdiscussed_in_filing Healthcare & Bio
topic_mentionINOdiscussed_in_filing Healthcare & Bio
topic_mentionINOdiscussed_in_filing Healthcare & Bio
topic_mentionINOdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001055726-26-000008EDGAR74K words
2025-03-182024-12-310001055726-25-000012EDGAR—
2024-03-062023-12-310001055726-24-000011EDGAR—
2023-03-012022-12-310001055726-23-000010EDGAR—
2022-03-012021-12-310001055726-22-000008EDGAR—
2021-03-012020-12-310001055726-21-000018EDGAR—
2020-03-122019-12-310001055726-20-000012EDGAR—
2019-03-122018-12-310001055726-19-000012EDGAR—
2018-03-142017-12-310001055726-18-000014EDGAR—
2017-03-152016-12-310001055726-17-000013EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001055726-25-000063EDGAR47K words
2025-08-122025-06-300001055726-25-000055EDGAR—
2025-05-132025-03-310001055726-25-000026EDGAR—
2024-11-142024-09-300001055726-24-000052EDGAR—
2024-08-082024-06-300001055726-24-000046EDGAR—
2024-05-132024-03-310001055726-24-000020EDGAR—
2023-11-092023-09-300001055726-23-000055EDGAR—
2023-08-092023-06-300001055726-23-000051EDGAR—
2023-05-102023-03-310001055726-23-000030EDGAR—
2022-11-082022-09-300001055726-22-000055EDGAR—
2022-08-092022-06-300001055726-22-000049EDGAR—
2022-05-102022-03-310001055726-22-000034EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060001193125-26-142885EDGAR22K words
2026-04-020001193125-26-138870EDGAR—
2026-03-120001055726-26-000009EDGAR—
2026-01-270001193125-26-024431EDGAR—
2025-12-290001193125-25-332322EDGAR—
2025-11-120001193125-25-275721EDGAR—
2025-11-100001055726-25-000064EDGAR—
2025-08-120001055726-25-000056EDGAR—
2025-07-070001193125-25-155830EDGAR—
2025-05-220001055726-25-000045EDGAR—

316 total filings indexed. 284 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001055726
TickerINO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersSan Diego, California

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 950d52be4a478b3bc7c63040986d7ad1fed30e5dce9deabb7e31dd7cbe266dd8
parent: fcefeb64d47085a37c055c0dc53a987841248c12d98fb06d1f485503b29b8feb
content hash: 5278c5730dda170abec399dfab5b20f2957b6f7e10363ffed7b77e30237baad9
signed: 2026-04-13T04:45:42.453Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf